VBI Vaccines Inc
OTC:VBIVQ

Watchlist Manager
VBI Vaccines Inc Logo
VBI Vaccines Inc
OTC:VBIVQ
Watchlist
Price: 0.0005 USD Market Closed
Market Cap: 14.3k USD

Relative Value

There is not enough data to reliably calculate the relative value of VBIVQ.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VBIVQ Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
57.6
Median 5Y
375.2
Industry
7.7
Forward
0.1
vs History
vs Industry
Median 3Y
-0.8
Median 5Y
-8.2
Industry
24.4
Forward
-0
vs History
vs Industry
Median 3Y
-1.2
Median 5Y
-13.1
Industry
21.1
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-12.1
Industry
22.9
vs History
vs Industry
Median 3Y
5.2
Median 5Y
8
Industry
3
vs History
vs Industry
Median 3Y
66.7
Median 5Y
362.5
Industry
8.2
Forward
-0.9
vs History
vs Industry
Median 3Y
-10.8
Median 5Y
-93.7
Industry
10.5
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-10
Industry
5.5
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-9.7
Industry
5.7
Forward
0.3
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-12.1
Industry
6.2
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-11.6
Industry
4.3
vs History
vs Industry
Median 3Y
2
Median 5Y
7.7
Industry
5.3

Multiples Across Competitors

VBIVQ Competitors Multiples
VBI Vaccines Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
VBI Vaccines Inc
OTC:VBIVQ
808.8k USD 0.1 -0 0.2 0.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 055 913.5 -161 862.7 -196 553 -194 310.1
US
Abbvie Inc
NYSE:ABBV
365.1B USD 6.3 98.1 16.1 23.4
US
Amgen Inc
NASDAQ:AMGN
159.5B USD 4.6 24.1 18.8 18.8
US
Gilead Sciences Inc
NASDAQ:GILD
147B USD 5.1 23.3 10.8 14.9
US
Epizyme Inc
F:EPE
94.1B EUR 2 068.6 -527.9 -574.8 -559.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
100.7B USD 8.8 27.7 20.4 21.3
AU
CSL Ltd
ASX:CSL
130.9B AUD 5.6 31 19 23.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
61.8B USD 4.3 13.9 12.5 14
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
58.8B USD 23.9 -184.3 -460.6 -316.2
US
Seagen Inc
F:SGT
39.3B EUR 19.9 -61.1 -65.9 -59.4
P/S Multiple
Revenue Growth P/S to Growth
US
VBI Vaccines Inc
OTC:VBIVQ
Average P/S: 3 096 187.3
0.1
90%
0
FR
Pharnext SCA
OTC:PNEXF
34 055 913.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
6.3
8%
0.8
US
Amgen Inc
NASDAQ:AMGN
4.6
4%
1.1
US
Gilead Sciences Inc
NASDAQ:GILD
5.1
4%
1.3
US
E
Epizyme Inc
F:EPE
2 068.6
N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
8.8
10%
0.9
AU
CSL Ltd
ASX:CSL
5.6
7%
0.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.3
4%
1.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
23.9
31%
0.8
US
S
Seagen Inc
F:SGT
19.9
30%
0.7
P/E Multiple
Earnings Growth PEG
US
VBI Vaccines Inc
OTC:VBIVQ
Average P/E: 36.3
Negative Multiple: -0
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 862.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
98.1
88%
1.1
US
Amgen Inc
NASDAQ:AMGN
24.1
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
23.3
189%
0.1
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.9 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27.7
N/A N/A
AU
CSL Ltd
ASX:CSL
31
16%
1.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.9
7%
2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -184.3 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.1 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
VBI Vaccines Inc
OTC:VBIVQ
Average EV/EBITDA: 14
0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 553 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.1
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
18.8
10%
1.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.8
6%
1.8
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.8 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
20.4
17%
1.2
AU
CSL Ltd
ASX:CSL
19
11%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.5
9%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -460.6 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -65.9 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
VBI Vaccines Inc
OTC:VBIVQ
Average EV/EBIT: 16.6
0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 310.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.4
28%
0.8
US
Amgen Inc
NASDAQ:AMGN
18.8
19%
1
US
Gilead Sciences Inc
NASDAQ:GILD
14.9
12%
1.2
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.5 N/A N/A
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.3
17%
1.3
AU
CSL Ltd
ASX:CSL
23.7
14%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
14
10%
1.4
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -316.2 N/A N/A
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.4 N/A N/A